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Summary
CRKL plays essential roles in cell signaling. It con-
sists of an N-terminal SH2 domain followed by two
SH3 domains. SH2 and SH3N bind to signaling pro-
teins, but the function of the SH3C domain has re-
mained largely enigmatic. We show here that the
SH3C of CRKL forms homodimers in protein crystals
and in solution. Evidence for dimer formation of full-
length CRKL is also presented. In the SH3C dimer,
a nuclear export signal (NES) is mostly buried under
the domain surface. The same is true for a monomeric
SH3C obtained under different crystallization condi-
tions. Interestingly, partial SH3 unfolding, such as oc-
curs upon dimer/monomer transition, produces a
fully-accessible NES through translocation of a single
b strand. Our results document the existence of an
SH3 domain dimer formed through exchange of the
first SH3 domain b strand and suggest that partial un-
folding of the SH3C is important for the relay of infor-
mation in vivo.
Introduction
Adaptor proteins are important in cellular signaling. By
definition, they lack a catalytic domain and act primarily
as organizers of multiprotein complexes. Adaptors are
typically composed of two or more protein interaction
domains and/or multiple binding sites for such domains.
The importance of adaptor proteins for cell signaling
was first recognized through the cloning of the retroviral
protein CT10 regulator of kinase (v-Crk), an oncogenic
adaptor that transforms avian fibroblasts and induces
sarcomas in chicken (Mayer et al., 1988). Subsequently,
two equivalent cellular proteins that are splice variants
of a single gene, c-Crk I and c-Crk II, were discovered
(Reichman et al., 1992; Matsuda et al., 1992). The shorter
*Correspondence: stephan.feller@cancer.org.ukvariant, c-Crk I, was acquired by the avian retroviruses
CT10 and ASV1 from their hosts (Mayer et al., 1988; Tsu-
chie et al., 1989).
v-Crk and c-Crk I each contain a single SH2 and SH3
domain. Their respective SH2 domains are known to
bind to specific phosphotyrosyl(pTyr)-containing epi-
topes, which encompass the core motif pTyr-x-x-Pro
(Songyang et al., 1993), while the SH3 domains bind
preferentially to proline-rich motifs with the core con-
sensus Pro-x-x-Pro-x-Lys (Knudsen et al., 1995; Wu
et al., 1995). The c-Crk II protein is about 12 kDa larger
than c-Crk I and contains an additional C-terminal SH3
domain (SH3C), which is separated from the first SH3
(SH3N) by a linker region of approximately 55 amino
acids. The same domain arrangement is also present
in Crk-like (CRKL), a homologous adaptor protein, which
is the product of a distinct gene (ten Hoeve et al., 1993).
CRKL is a major substrate of Bcr-Abl, an oncogenic ki-
nase intimately linked to the development of human
chronic myelogenous leukemia (CML) (Oda et al., 1994;
ten Hoeve et al., 1994). c-Crk II and CRKL are known
to be involved in the signaling cascades initiated by sev-
eral cell-surface receptors, including growth-factor-
activated kinases and integrins (reviewed in Buday
[1999]; Furge et al. [2000]; Feller [2001], and Chodnie-
wicz and Klemke [2004]). Targeted disruption of the
CRKL gene has shown that CRKL also plays an impor-
tant role in neural crest development (Guris et al.,
2001; Moon et al., 2006; Guris et al., 2006).
No signaling partners or binding motifs have emerged
for the SH3C domains of c-Crk II and CRKL (67% se-
quence identity) from peptide library, phage display,
and other screens. However, several reports in the liter-
ature indicate that the SH3C is nevertheless functionally
important. Mutation or deletion of the SH3C domain of c-
Crk II massively increases the phosphorylation of the
large docking protein p130Cas in transfected rat 3Y1 fi-
broblasts (Ogawa et al., 1994), indicating an inhibitory
role for the SH3C in this signal transduction pathway.
Conversely, it has been shown that a mutant cell line in-
capable of oncogenic transformation and EGF receptor
signaling contains a c-Crk II protein with mutations in the
SH3C domain (Kizaka-Kondoh et al., 1996). Later stud-
ies showed adverse effects on FAK, c-Abl, and
Dock180/Elmo/Rac signaling upon forced expression
of c-Crk II proteins with SH3C domain mutations (Zvara
et al., 2001; Akakura et al., 2005; Reichman et al., 2005).
However, in none of these reports did a detailed picture
of the molecular action of the c-Crk II SH3C domain
emerge, which would have provided clear indications
for the functionality of the homologous CRKL SH3C. A
single report in the literature has so far directly implied
a function for the CRKL SH3C domain. Felschow et al.
reported the binding of a cytoplasmic region from the
cell-surface molecule CD34 to the CRKL SH3C domain
(Felschow et al., 2001). The proposed binding epitope
was a short amino acid stretch in the juxtamembrane re-
gion of CD34, but the interaction was not studied further.
There is also compelling evidence for a function of the
C-terminal SH3 domains of Crk family proteins in
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1742Figure 1. SH3 Domains of Human Small SH2/SH3 Adaptors
Sequence alignment of SH3 domains (A). Secondary structure elements of the CRKL SH3C monomer and dimer are marked at the top and feature
along corresponding residue sections. Red stars mark residues of the NES present in Crk II and CRKL. Bold-type face or colors were manually
assigned to individual residues. Red-colored residues are conserved in at least 70% (12 of 17); green residues are conserved throughout all SH3
domain sequences. Bold letters indicate residues that are conserved in most SH3 domains but not in the C-terminal SH3 domains of CRKL and c-
Crk II. Additionally, unique cysteine residues in the C-terminal SH3 domains of CRKL and c-Crk II are emphasized by yellow letters on blue back-
ground. Within the consensus box, an asterisk indicates identity, a double-point conservation, and a single-point semiconservation of residues
across the aligned sequences. Phylogenetic tree of the selected SH3 domains (B), highlighting the close relation between Crk II and CRKL SH3C
on a fairly distinct branch, which diverges considerably from other SH3 domains of small SH2/SH3 adaptors.nucleocytoplasmic shuttling. These domains contain a
LALEVGEL/IVKV motif conserved from man to Xenopus,
which acts as a nuclear export sequence (NES) and
binds to Crm1 (Smith et al., 2002). A mutant c-Crk II pro-
tein lacking an intact NES promotes apoptosis, presum-
ably through an SH2 domain interaction with the nuclear
tyrosine kinase Wee1 (Smith et al., 2000). Key residues
of this NES are highlighted in Figure 1A. CRKL has mul-
tiple functions in the cytoplasm of cells (Feller, 2001) but
has also been repeatedly reported to form heterodimers
with the transcription factor STAT5 (Oda et al., 1998;
Ozaki et al., 1998; Ota et al., 1998; Fish et al., 1999; Rho-
des et al., 2000). The maintenance of appropriate tem-
poral and spatial CRKL concentrations in different
subcellular compartments, for example by nucleocyto-
plasmic shuttling, is therefore likely to be crucial for its
actions.The alignment of all SH3 domains from small human
SH2/SH3 adaptors clearly shows that the SH3C do-
mains of CRKL and c-Crk II differ in several amino acids,
which are otherwise conserved in all or most SH3s ana-
lyzed here (Figure 1A, diverging amino acids within the
CRKL and c-Crk II SH3C domains in bold black). Gener-
ation of a phylogenetic tree for the SH2/SH3 adaptor
SH3 domains accordingly shows that the CRKL and
c-Crk II SH3C domains are particularly dissimilar from
all other SH3s (Figure 1B).
In this study, we have initially analyzed the putative
binding motif of CD34 for the CRKL SH3C domain with
isothermal titration calorimetry. Our results suggest
that the previously proposed CD34 motif does not bind
directly to the CRKL SH3C domain. Subsequently, puri-
fied CRKL SH3C domain protein was crystallized, and its
atomic structure was analyzed by X-ray diffraction. In
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by analytical ultracentrifugation (AUC) and gel filtration
chromatography. These studies showed that the CRKL
SH3C, as well as full-length CRKL, have the ability to
form homodimers and that the previously reported
NES is likely to be fully accessible only during the trans-
location of a single b strand at the N-terminal end of the
SH3 domain fold. Such translocation takes place during
the interchange between dimeric and monomeric states
of the native domain, both of which we have captured
through crystallization.
Results and Discussion
CRKL Association with CD34
Based upon the results of Fackler and colleagues (Fel-
schow et al., 2001), we investigated the binding of the
purified CRKL SH3C to the implicated epitope of
CD34. For this, peptides corresponding to the juxta-
membrane region in the cytoplasmic tail of CD34 were
synthesized, and their binding analyzed by isothermal ti-
tration calorimetry (ITC), by using a previously described
set up suitable for quantification of SH3 domain interac-
tions (Harkiolaki et al., 2003; Lewitzky et al., 2004). We
were unable to detect even substandard binding of the
CD34-derived motifs to the CRKL SH3C domain by ITC
(M. Lewitzky, personal communication). Several expla-
nations for this are possible: the interaction of CD34
and CRKL could occur indirectly, i.e. via a bridging pro-
tein, or it may require a conformational arrangement of
CD34, which only exists in the native full-length CD34
protein. Alternatively, the direct binding affinity may be
very low, and additional components may lead to a sta-
bilization of the complex in vivo. Very low affinity interac-
tions of SH3 domains with a Kd in the millimolar range
can be biologically important (Vaynberg et al., 2005)
but are not easily detected with ITC.
In the absence of a clearly defined direct binding
partner of the CRKL SH3C domain, the isolated SH3C
domain was expressed, purified, and crystallized in the
hope that the resulting atomic structure would provide
us with insights into the functionality of this domain. Fur-
thermore, atomic structures of the native domain would
reveal the precise architecture and accessibility of the
NES site on CRKL and hence increase our understanding
of protein associations involved in nuclear trafficking.
The Atomic Structures of CRKL SH3C
The atomic structures discussed have been determined
through X-ray crystallography. We tested two crystal
forms, which contained different association states of
the native CRKL SH3C, namely a monomer and a homo-
dimer. In both cases, the stock protein solution was the
same. This disparity of native conformations was in
agreement with biochemical data indicating that the
full-length CRKL can also form homodimers in solution
(discussed below). Stabilization of dimer versus mono-
mer and vice versa could have been promoted by the
reservoir solution used. Crystals of the SH3C domain
as a dimer were formed under what could be considered
as near-physiological conditions, with a mere 5% of pre-
cipitant at an ionic strength ofw250 mM (for details see
Experimental Procedures). However, crystals of CRKL
SH3C as a monomer were formed under the influenceof multiple precipitants as well as a cryoprotectant, all
at extreme concentrations far beyond physiological
levels. As such, this reservoir solution appears to pro-
mote dimer dissociation while stabilizing the monomer
selectively.
A CRKL SH3C construct encoding for the C-terminal
66 amino acids of CRKL (molecular weight of 7.4 kDa)
was used to express the domain. The first CRKL SH3C
structure was solved by molecular replacement using
a P41212 crystal that contained one SH3 domain per
asymmetric unit. The visible structure comprised of
60 residues, and the final model was refined against
99.6% complete 2.8 A˚ resolution data to an Rwork of
27.8 (Rfree = 31.7) and good stereochemistry (all residues
in favored or allowed regions of the Ramachandran plot)
(Table 1). The monomeric CRKL SH3C exhibits the typi-
cal SH3 b-barrel fold (see Supplemental Data, Figure S1,
available with this article online). It features five
b strands, b1–b5 (residues 4–6, 26–32, 38–41, 48–51,
and 55–57) as well as a 310 helix of residues 52–54 (Fig-
ure 1A). The RT loop, present between b1 and b2, is sta-
bilized at its ends by a b bridge between Arg10 and
Leu22 and is locked onto the b barrel through mostly hy-
drophobic interactions as well as an additional b bridge
between Ala19 and Leu49 from b4. The n-Src loop fea-
tures modestly between b2 and b3 spanning from
Asn34 to Gln38. No regular secondary structure is
evident in either loop, in line with all structurally charac-
terized SH3 domains to date.
The second CRKL SH3C structure was solved by mo-
lecular replacement, by using the monomeric structure
as a model, and was present in a P6122 crystal with an
intertwined SH3 dimer per asymmetric unit (124 resi-
dues in total). The atomic model of the dimer was refined
against a 99.7% complete 2.5 A˚ dataset to an Rwork of
26.3 (Rfree = 30.9). The architecture of the dimer is prac-
tically identical to that of individual monomers for the
C-terminal bulk of the structure. However, each domain
in the dimer looses its RT loop as it extends its N-termi-
nal and positions its b1 onto the canonical b1 position of
the neighboring monomer, while the latter adopts the
same fold on its partner (Figures 2A–2C). There is little
change in the architecture of each of the partners in
the dimer compared to the monomer structure (Fig-
ure 2D), with an rmsd of 0.87 A˚ upon superposition of
Ca atoms over the bulk of the domain excluding some
terminal residues, nine RT loop residues, where cross-
over occurs, and four residues corresponding to the
b hairpin between b3 and b4. Strand exchange between
domains further promotes the formation of a new
b strand (denoted b* throughout the text and related fig-
ures) between residues of the former RT loops. The con-
served secondary structure features within each domain
in the dimer are five b strands (b1 residues 2–6, b* 13–15,
b2–b4 27–33, 38–43, and 46–51, respectively), with b5
reduced to a b bridge at Lys56. Each subunit can be
superimposed onto its partner within the dimer with an
overall rmsd of 0.41 A˚ for its core Ca atoms (residues
3–33 and 39–58 as terminal residues were excluded
along with five residues of the nSrc loop that exhibit
some variation between subunits).
Within the crystalline arrangement of the dimer,
symmetry-imposed association promotes tetramer for-
mation. Two intermolecular disulphide bonds between
Structure
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bonded tetramers. Consequently, respective b ladders
overlap (cross-stagger) resulting in the burial of a total
of 1033 A˚2 per dimer. Although this may be an artifact
promoted through crystal packing, higher order associ-
ations such as these might be involved in recruitment
and signal amplification in the context of localized oxi-
dative events (see Supplemental Data for further details
and discussion and Figure S4).
Table 1. Data Collection and Refinement Statistics
Monomer Dimer
Data Collection
Resolution (A˚)a 30–2.80 (2.90–2.80) 30–2.50 (2.59–2.50)
Space group P41212 P6122
Cell dimensions (A˚) a = b = 53.28,
c = 51.19
a = b = 71.32,
c = 146.43
Cell angles () a = b = g = 90 a = b = 90, g = 120
Solvent content (%) 54.91 68.42
Wavelength (A˚) 1.77 1.54
Total data 170,871 361,319
Unique data 2,035 8,176
Completeness (%) 99.6 (99.5) 99.7 (100)
I/s(I) 34.3 (3.2) 16.74 (1.09)
Rmerge (%)
b 10.1 (99.9) 15.6 (99.9)
Refinement
Number of unique
reflections used
2,015 8,123
Rwork
c(Rfree)
d 28.7 (35.33) 26.27 (30.90)
Rmsd bonds (A˚) 0.009 0.014
Rmsd angles (deg) 1.670 1.83
Average Be main
chain (A˚2)
81.22 55.40
Rmsd main-chain
bond B (A˚2)
3.65 2.99
Average Be side
chain (A˚2)
84.33 59.41
Rmsd side-chain
bond B (A˚2)
4.81 5.03
Number of atoms
(residues) per
asymmetric unit
474 (60) 978 (124)
Model Quality (Ramachandran Plot)f
Residues in most
favored regions (%)
58.8 88.5
Residues in additional
allowed regions (%)
35.3 9.6
Residues in generously
allowed regions (%)
5.9 1.9
Number of individual
domains/asymmetric
unit
1 2
Number of residues
(number of atoms)/
asymmetric unit
60 (472) 124 (978)
a Values in parentheses correspond to the highest resolution
shell.
b Rmerge= SjSh (jIj.h 2 <Ih>j) / SjSh(<Ih>), where h is the unique reflec-
tion index, Ij.h is the intensity of the symmetry related reflection, and
<Ih> is the mean intensity.
c R = ShjjFojh 2 /jFcjhj/ShjFojh, where h defines the unique reflec-
tions.
d Calculated on a random 5% of the data.
e B = <u2> 8p2 / 3, where <u2> is the mean square atomic dis-
placement.
f Values from PROCHECK (Laskowski et al., 1993).The Putative Ligand-Binding Surface of CRKL SH3C
To date, despite considerable efforts, there are no bind-
ing partners identified for CRKL SH3C. It is interesting
nevertheless to identify outstanding features present in
its putative binding site. Three representative structures
were superimposed onto the domain to gain insight into
its potential binding mode: Crk SH3N, which binds
PxxPxK/R motifs (1CKA.pdb and 1CKB.pdb), Grb2
SH3N binding PxxPxR, and Mona/Gads SH3C as a rep-
resentative of the atypical RxxK binding SH3 domains
(1OEB.pdb). Compared to these domains, CRKL SH3C
lacks the strong negative potential to bind positively
charged residues, such as arginine or lysine, as it misses
at least two of the charged residues involved, so it is un-
likely it will engage in charged interactions of this nature
although some residual negative potential still persists
in that location (Figures 3A and 3B). Remarkably, the ab-
sence of a tryptophan in position 38, which appears
strictly conserved in other SH3 domains (Figure 1A), re-
sults in a relative depression of the binding groove and
the loss of hydrophobic stacking potential (Figure 1B).
Although some stacking potential remains (a histidine
where tyrosine normally resides and a conserved pro-
line), it is unlikely it will promote strong binding with in-
coming prolines of a PxxP motif if the ligand orients itself
in a canonical fashion. Strikingly, the N-terminal Arg10
produces an impressive pool of positive charges that
appears to dominate the midregion of the canonical
binding grove (Figure 3B). It would be reasonable then
to conclude that a binding partner would need to com-
plement this with negatively charged residues, in which
case we are looking into an entirely novel motif that has
to be yet identified. Dimerization should not affect bind-
ing as crossover takes place at the tip of the RT loop,
which, in itself, remains largely in place with regards to
the canonical binding groove (Figure 3C). A projected
full-length CRKL dimer, however, could assist in signal
modification within signaling networks through local
amplification of the CRKL modules (see Supplemental
Data).
Further Evidence of Native Association States
for CRKL and Its SH3C Domain
Sedimentation equilibrium analytical ultracentrifugation
(AUC) of the CRKL SH3C under near physiological con-
ditions (50 mM HEPES [pH 7.5], 100 mM NaCl) over
a range of concentrations indicated that it is a dimer in
solution, with further higher-molecular-weight assem-
blies promoted by increased concentrations (Figure 4A).
Extrapolation to infinite dilution over the first four data
points gives a molecular weight of 15,471 6 837 Da,
which is in agreement with the theoretical molecular
weight (14,890 Da) of a CRKL SH3C dimer (the last
data point was excluded due to crowding effects). Sed-
imentation velocity AUC revealed a sedimentation
boundary with several peaks (Figure 4B), which could
be deconvoluted into three species with sedimentation
coefficients (s) of 1.4S, 1.9S, and 3.0S (S = Svedberg
unit). The major peak was present at 1.9S, followed by
one at 3.0S, while a peak at 1.4S represented a minor
species. The sedimentation coefficients calculated
from the crystal structures of the CRKL domain mono-
mer, dimer, and tetramer are estimated at 1.31S–
1.56S, 1.80S–2.04S, and 2.84S–3.22S, respectively,
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Schematic representation of the CRKL SH3C dimer (A), where the two polypeptide chains are colored green and red, respectively, with all
b strands numbered from N to C terminus and a second view of the same structure (B) produced through a 90 clockwise rotation around the
x axis of (A). The second orientation (B) is also viewed as a space-filling model (C). (D) Ca models of the SH3C dimer and superimposed mono-
mers. The two polypeptide chains in the dimer are colored green and red, respectively, while the monomers are in gray. The structures were
superimposed in LSQKAB (Kabsch, 1976) with equivalences of core SH3 fold residues across species. Orientation same as in (A).allowing for varying degrees of solvation. Using the
structure derived estimates for s, the three peaks in
the sedimentation profile can be identified with the mo-
nomeric, dimeric, and tetrameric populations of the
CRKL domain, where the monomeric form is the minor
species. In order to estimate the concentrations of
each species observed in the c(s) profile, the area of
each equivalent fitted Gaussian peak was calculated
as described in the Experimental Procedures. This indi-
cated that of the peaks observed for CRKL SH3C, 11%
of the protein was monomeric, 56% dimeric, and 5% tet-
rameric. The concentration of the sample used in the ex-periment was 138 mM (1.03 mg/ml) and therefore a KD
for the monomer-dimer interaction of 6.1 mM can be
estimated.
The experiment was repeated in the presence of
50 mM DTT to confirm the identity of the 3.0S peak as
the SH3C tetramer. In this case, the monomeric and di-
meric peaks persisted (Figure 4B), but the tetrameric
peak was much reduced if not absent; this is in line
with the stabilization of the tetrameric form by disul-
phide bonds. Both in the presence and absence of
DTT, the sedimentation profiles showed a long tail to-
ward higher s values; this likely arises from the formation
Structure
1746Figure 3. Comparative Surface Representations of the CRKL SH3C Monomer and a Representative SH3 Domain Exhibiting the Canonical SH3
Binding
(A) Electrostatic surface representation of c-Crk II SH3N in complex with a peptide of the canonical PxxPxK motif (1CKA.pdb). Trp169 (the typ-
ically conserved Trp, missing in CRKLSH3C) is labeled.
(B) Electrostatic surface representation of the CRKL SH3C monomer in divergent stereo with representative loops and binding site residues la-
beled. SH3 domains in both (A) and (B) are in exactly the same orientation after superposition for comparison purposes.
(C) Surface representation of the CRKL SH3C dimer with normalized electrostatic potential in agreement with the monomeric structure.of transitory associations into higher-order assemblies
consistent with side-on intermolecular interactions be-
tween strands.
Full-length recombinant CRKL was also used for both
sedimentation equilibrium and velocity experiments. A
fit to a single-species model is shown in Figure 4A for the
equilibrium experiment. The full-length CRKL gave the
following molecular weights: at 12,000 rpm, 75,961 6
739 Da; at 15,000 rpm, 63,372 6 485 Da; and at21,000 rpm, 44,001 6 236 Da. This pattern of apparent
molecular weight loss with increasing speed is indica-
tive of the presence of high molecular weight species
(aggregates) that are progressively removed from solu-
tion as the speed of the rotor is increased. In line with
this, the velocity profile of full-length CRKL contains
a number of peaks, indicative of the presence of a num-
ber of discrete species of increasing molecular weight in
the sample (Figure 4B). The positioning of these peaks,
CRKL SH3C Dimer/Monomer Transition Exposes NES
1747Figure 4. Biochemical Characterization of the Distribution of Associative Species in Solution and Corroborating Thermal-Parameter Distribution
within Crystalline Arrangements
Sedimentation equilibrium of CRKL domain and full-length protein (A). Data for the SH3 domain uses the left-hand y axis and bottom x axis where
the apparent whole-cell molecular weight (kDa) is plotted against sample concentration (mg/ml) (green circles). The lower four concentrations
were fitted with a straight line (orange) giving the molecular weight at infinite dilution where the line cuts the y axis. The right-hand y axis and top x
axis represent values relating to the full-length CRKL. The interference optics sample equilibrium distribution (fringe shift versus radial cm) is
shown (blue symbols) fitted with a single-species equation with ULTRASPIN (Altamirano et al., 2001) (red line). Also shown is the sedimentation
velocity of CRKL SH3C domain and full-length protein (B). Orange squares represent the c(s) profile for the CRKL SH3C domain. The Gaussian fits
to the first three species in the profile (s = 1.4S, 1.9S, and 3.0S) are in green. These correspond to the monomer, dimer, and tetramer, structures of
which are shown on the right along with their corresponding range of calculated sedimentation coefficients (protein backbone drawn as a ribbon
with hydrodynamic beads calculated by using AtoB [Byron, 1997] drawn on top). Red circles represent the c(s) profile for the CRKL domain with 1
mM DTT. In blue are the Gaussian fits to the remaining (after DTT addition) two species (monomer and dimer). The c(s) profile for full-length CRKL
is depicted by magenta crosses and displays a complex distribution of sedimenting species. Fractions from size-exclusion chromatography (C)
of HeLa extracts after SDS-PAGE separation, western blotting, and ELC detection of CRKL on blue light-sensitive autoradiography film. Ca tem-
perature factor plot (D) of polypeptide chains in the monomeric (in red) and dimeric (in blue and green) folds. Absolute mean square atomic dis-
placements are dependent on data resolution across crystals, and in this case, values reflecting the dimeric SH3C residues have been normal-
ized to the monomeric structure by addition of a constant value (20) for the purposes of relative distribution comparisons. Secondary structure
features are labeled and enclosing the residue numbers involved in their formation, while double headed arrows indicate the stretches associ-
ated with the three loops present in an SH3 fold (RT, nSrc and distal loop, respectively).at 1.9S, 2.5S, 3.5S, 4.6S, and 7.5S are consistent with the
presence in the sample of monomeric, dimeric, and
higher assemblies of full-length CRKL. As the speed of
the rotor is increased, the heavier species are pellettedfrom solution and the apparent whole-cell molecular
weight, measured by fitting the equilibrium profile of
a dynamic system such as this to a single-species
model, falls.
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lar radius of 33 A˚ for both the full-length recombinant
CRKL as well as the native CRKL derived from adherent
HeLa cells (Figure 4C), which, assuming an overall glob-
ular structure, is equivalent to an apparent molecular
weight of 55 kDa (the theoretical MW of a CRKL mono-
mer is 33.8 kDa). The multidomain CRKL (SH2-SH3N-
SH3C) is likely to conform to a beads-on-a-string archi-
tecture where the three domains are linked in tandem
but do not structurally interfere with each other. It is con-
ceivable that such a protein could be delayed as it tra-
verses the chromatography matrix, thus appearing
smaller than expected, as terminal domains sample
the available channels that would have been inaccessi-
ble to a typical single-fold protein of similar molecular
weight. Taking therefore into account the relative uncer-
tainty of this technique, these results appear to imply
that CRKL, either as a recombinant construct expressed
in bacteria or as endogenous protein derived from a hu-
man cell line, is a dimer in solution (see Supplemental
Data and Figure S3 for further biochemical characteriza-
tion by crosslinking).
The atomic structures available provide additional in-
sight into the origins of dynamic states of the domain
fold in CRKL SH3C. By plotting the distribution of Ca
temperature factors B (B = <u2> 8p2 / 3, where <u2> is
the mean square atomic displacement), a clear differ-
ence between the monomer and respective subunits
within the dimer becomes apparent (Figure 4D). While
loops in both structures appear to retain a rather high vi-
brational profile overall, compared to the core structural
elements, the dimer is considerably less flexible in the
RT region. The RT loop, being the feature that un-
dergoes restructuring in the transition between mono-
mer and dimer, appears thus to have a pivotal role in
dimer/monomer interconversion. As such, it could ac-
count for the propensity of the monomer for partial un-
folding, while at the same time, its rebirth as part of
a b ladder in the dimer (b*-b*) might promote the overall
stability of the respective dimeric architecture.
Association States of CRKL and Their Implication
in Nuclear Trafficking
The SH3C domain of CRKL has yet to be fully character-
ized as to the nature of interactions it experiences and
the pathways in which it is implicated. A recent report
on the closely homologous c-Crk II (93% residue homol-
ogy between SH3C domains) provided evidence for di-
rect association to Crm1 through an NES located on
its SH3C domain (Smith et al., 2002), in compliance
with the generic F-x2-3-F-x2-3-F-x-F (F = L,I,V,F,M and
x is any amino acid) motif (la Cour et al., 2004). c-Crk II
can thus be shuttled out of the nucleus as a preventative
measure against initiation of proapoptotic signals gen-
erated through its association with the kinase Wee1.
The same motif is present in CRKL SH3C, which implies
that CRKL might also be involved in nuclear shuttling in
a similar fashion, possibly within the context of its own
distinct signaling tasks, for example the well established
heterodimerization with transcription factor STAT5. Fur-
ther experiments will need to confirm whether the CRKL
SH3C NES is indeed functional; however, based on se-
quence identity (see Supplemental Data, Figure S2), it
is reasonable to assume that a fully functional NES onthe homologous site is a distinct possibility. Further-
more, the 3D profile of this projected NES on CRKL
SH3C provides valuable insight to the atomic nature of
c-Crk II binding to Crm1.
The key residues of the proposed NES (Leu20, Val24,
Val 28, and Val30) are mostly solvent inaccessible in the
native CRKL structure, be that a dimer or a monomer
(Figure 5). Leu20 is completely buried within the hydro-
phobic core of the domain underneath the b sheet com-
prised of b2–b4 and is not likely therefore to be directly
involved in associations with Crm1. Val24 is clearly lo-
cated on the domain surface. It is the last residue to
maintain an orderly bonding pattern with b1 as it pro-
ceeds toward the periphery of the SH3. Val28 and
Val30 are both buried within the hydrophobic core of
the domain, locked onto position also by b1 that com-
pletely obscures both residues from any incoming bind-
ing partners and locks them well within the innermost
core of the domain. However, both of these residues
are presumed to be intimately involved with Crm1 bind-
ing because mutation of either results in the abrogation
of Crm1 binding to c-Crk II without any apparent loss of
solubility (Smith et al., 2002).
The 2.5 and 2.8 A˚ SH3 folds presented herein conform
to the archetypal SH3 fold present in all well docu-
mented structural studies of such domains, thus they
appear to be genuinely stable states for the domain ar-
chitecture. However, the presence of two alternate as-
sociation states may provide a viable hypothesis for
the character of the associations of c-Crk II with Crm1
in the process of nuclear export. According to the bulk
of our biochemical data, CRKL, and specifically its
SH3C domain, exists as a dimer in solution. However,
we were able to favor monomer formation in the crystal-
lization medium, an event that must give rise to, or in-
deed result from, a transiently exposed NES on each
participating subunit. The projected NES motif of
CRKL, and by inference the NES of c-Crk II, could be
sampled by environmental factors during structure fluc-
tuations inherent to the nature of this domain or become
accessible upon and because of association with Crm1.
If it is assumed that the two proteins can be found in the
immediate environment of each other, Crm1 might ini-
tially associate with CRKL through residues clearly ac-
cessible, such as Val24 or Ile27 (the latter of which, ac-
cording to Smith et al., is required for binding), and in
essence ‘‘unroll’’ the SH3C domain N-terminal region,
fully exposing the complementary NES site. In this
model, Val20 would be essential for core stability be-
cause it locks b2 under the curved b sheet formed by
b3–b5 thus maintaining the core fold of the domain.
The NMR solution structure of the highly homologous
c-Crk II SH3C as a monomer was published while this
report was being reviewed (Muralidharan et al., 2006).
It is largely in agreement with our findings and was
reported along with complementary equilibrium dena-
turation measurements and fluorescence-detected
stopped-flow experiments that provided thermody-
namic measurements of the SH3C folding process. It
was therein established that low nanomolar affinity of
Crm1 would sufficiently compensate for the free-energy
loss incurred during domain unfolding as seen elsewhere
(Petosa et al., 2004) and would appear to validate our de-
ductions based on the atomic resolution data available.
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sition of Its NES
Surface representations of the CRKL SH3C
dimer in two orientations with the two do-
mains in tandem on the x-y plane (A) and
the same rotated by 30 counterclockwise
along the y axis (B). The two views are given
in two panels each where both of the domains
are drawn as surface representations of
green or red (top), respectively, or one do-
main is seen as an atomic model for clarity
(bottom). Accessible surfaces corresponding
to residues of the NES are colored yellow.
Residues Ile27 and Phe58 appear continuous
due to their close proximity.CRKL SH3C, SH3 Dimers, Domain Swapping,
and Hidden Motifs
SH3 domain homo- and heterodimerization has been re-
ported in atomic detail on a number of occasions and
encompasses a range of molecules involved in cell sig-
naling (Figure 6) (see Supplemental Data for a more ex-
tensive discussion). Additionally, the plasticity of the
SH3 fold has been convincingly exhibited through struc-
ture-informed mutagenesis on PSD-95, whereupon
a five proline linker results in preferential dimer forma-
tion between domains (McGee et al., 2001). Folding ki-
netic analyses of the Src SH3 domain, after point muta-
tions along its length, confirmed that within an SH3
domain strands b1 and b2, the RT loop and the 310 helix
can unfold without compromising the SH3 fold overall
(Riddle et al., 1999). Furthermore, NMR studies of the
native state of a-spectrin SH3 domain confirm that anyof its residues can be exposed without overall structural
compromise (Sadqi et al., 1999) (see Supplemental Data
for further discussion).
In general, domain swapping has been documented
repeatedly and found implicated in activation and regu-
lation of protein function as well as increased thermo-
stability (Rousseau et al., 2003). It has also been sug-
gested that certain folds display a propensity for
domain swapping, which is further ensured through
the positioning of key residues (most commonly pro-
lines) in the exchange region (Ding et al., 2006).
Ultimately, the prospect arises that the observed two-
state equilibrium we witness in the case of CRKL SH3C
is only the byproduct of a local unfolding phenomenon
that aims to expose a hidden NES. As such, this behav-
ior can be indicative of a potentially common yet pres-
ently under-studied structural promiscuity effecting
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Ribbon representations of SH3 fold dimers
(partner subunit polypeptide chains in green
and red, respectively) of Vav and Grb2 (A)
(Nishida et al., 2001), Grap2 (Mona/Gads) (B)
(Harkiolaki et al., 2003), KorB-C (C), p47phox
(D) (Delbruck et al., 2002), and Eps8 (E)
(Kishan et al., 1997). The yellow circle in (B)
represents a crucial divalent metal ion.novel functional characteristics on known proteins. A
well documented example of such propensity is the
structurally unrelated focal adhesion targeting (FAT) do-
main of focal adhesion kinase (FAK), whose four-helix
bundle assembles as either a monomer or a dimer (Arold
et al., 2002; McGee et al., 2001). In both, tyrosine 926 be-
comes available to kinase action only upon partial un-
folding of the domain, an event that is ultimately also re-
sponsible for dimer formation (Dixon et al., 2004).
The function of the CRKL SH3C domain has been un-
clear for a long time. Here, we provide evidence, both
crystallographic and biochemical, for alternate associa-
tion states that could promote nuclear export through
the dislocation of a single SH3C domain b strand. In do-
ing so, a plausible model of CRKL targeting by the nu-
clear protein export complex Crm1/Ran$GTP emerges
that accounts for the inaccessibility of a resident NES
site. This model can hereafter be further tested by muta-
tional analysis and binding studies. By and large the
most intriguing structural aspect of this study appears
to be the dynamic structural state inherent in this subset
of SH3 domains (and possibly other SH3 domain rela-
tives). As such, the fluid architecture documented here
could reflect a whole new physiological role for SH3
domains other than the prescribed surface-docking
function.
Experimental Procedures
Primary Structure Alignment and Phylogenetic Tree for SH3
Domains of CRKL and Related Small Adaptor Proteins
Sequences of human full-length proteins were retrieved from the
NCBI Entrez Protein Database. Limits of individual SH3 domains
were determined by a Pfam database HMM search (http://pfam.
janelia.org/) (Bateman et al., 2004). Subsequent analyzes were per-
formed with version 3.1 of the ‘‘Molecular Evolutionary Genetics
Analysis’’ (MEGA) package (http://www.megasoftware.net/) (Kumar
et al., 2004). The initial alignment was created with the incorporated
ClustalW algorithm (Thompson et al., 1994). The phylogenetic treewas constructed by using the ‘‘neighbor-joining’’ algorithm (Saitou
and Nei, 1987) with ‘‘number of differences’’ as method for calcula-
tion of distances between the sequences and ‘‘complete deletion’’
for treating gaps in the alignment.
SH3 Domain Expression and Purification
The pGEX-CRKL SH3C construct was a kind gift of Brian J. Druker
and generated as described previously (Heaney et al., 1997). This
construct was used to transform E. coli BL21 (DE3) cells, which
were induced to express at OD600 1.4 with 0.1 mM IPTG in terrific
broth at 37C for 4 hr with shaking. The bacterial culture was there-
after centrifuged, and the pellets resuspended and sonicated in
50 mM Tris (pH 7.5) with, 100 mM NaCl, 13Complete protease inhib-
itor cocktail (Roche) and 0.2 mM phenylmethylsulfonyl fluoride
(PMSF). The lysates were further centrifuged, and the clear superna-
tant applied to GSH-Sepharose beads (Amersham Biosciences) and
allowed to bind overnight at 4C on a nutator. The loaded resin was
then packed in a chromatography column, washed with three times
with ten column volumes of 50 mM Tris (pH 7.5), 100 mM NaCl, and
incubated with five units of Thrombin per milligram of immobilized
GST-CRKL SH3C overnight at ambient temperature while nutating.
The cleaved domain solution was thereafter drained from the col-
umn, concentrated, and further purified through FPLC size-exclu-
sion chromatography (Sephadex 75 16/60; Amersham Biosciences)
into 50 mM HEPES (pH 7.5), 100 mM NaCl.
Crystallization and Data Collection
The purified CRKL SH3C was concentrated to 43 mg/ml and used in
sitting drop vapor diffusion crystallization screens. Two types of dif-
fraction quality crystals were produced. Crystals of the domain as
a monomer (roughly cubical, with dimensions of 0.2 3 0.2 3
0.2 mm3) were formed under equilibrium conditions of 1.7 M ammo-
nium soleplate, 25.5% w/v PEG-8000, 0.085 M sodium cacodylate
(pH 6.5), and 15% glycerol (Crystal Screen Cryo, Hampton Research)
within 2 days at room temperature. These were vitrified through
transfer directly into a nitrogen stream (100 K). Diffraction data to
3.0 A˚ were collected on BM14 at the European Synchrotron Radia-
tion Facility, Grenoble, France. Crystals of the dimeric form (rod
like, with dimensions of 0.4 3 0.2 3 0.2 mm3) were formed under
equilibrium conditions of 0.01 M MgCl2, 5% w/v PEG-8000, 0.2 M
KCl, 0.05 M MES (pH 5.6) (Natrix, Hampton Research) within
a week at room temperature. Crystals were cryoprotected through
transfer into mother liquor containing 25% glycerol. Diffraction
data were collected to 2.5 A˚ on a CuKa rotating anode (Rigaku
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1751MicroMax-007, 40 mA, 20 kV) with osmic-blue mirrors and a 30 cm
imaging plate (MAR research). Data were integrated and scaled
with DENZO and SCALEPACK (Otwinowski, 1993; Otwinowski and
Minor, 1997) (Table 1).
Structure Solution and Refinement
Data collected from type I crystals, formed under conditions of ex-
treme ionic strength, were used in molecular replacement phasing
trials with various existing SH3 domains, and a solution was ob-
tained in AMoRe (Navaza, 1994) with the SH3 domain of p47phox
(1UEC) (Yuzawa et al., 2004). The resulting model was rebuilt in the
program O (Jones et al., 1991) and refined with CNS (Brunger
et al., 1998). Refinement and model quality statistics are summa-
rized in Table 1. The refined CrkL-SH3C monomer model was there-
after used as a molecular replacement model for the data collected
on a type II crystal with AMoRe. Two molecules were successfully
placed in the asymmetric unit, and several rounds of rebuilding
and refinement followed, resulting in the atomic model of an inter-
twined domain homodimer. Refinement and model quality statistics
are given in Table 1.
Structure and Surface Representations
Atomic structure representations were created with BOBSCRIPT
(Esnouf, 1997, 1999) and rendered with Raster3D (Merritt and Mur-
phy, 1994). Surface representations were done with GRASP (Nich-
olls et al., 1991).
Analytical Ultracentrifugation
Sedimentation equilibrium experiments were performed in a Beck-
man Optima XL-I analytical ultracentrifuge, as previously described
(Sutton et al., 2004). Briefly, CRKL SH3C in 50 mM HEPES (pH 7.0),
50 mM NaCl was used at concentrations ranging from 0.75 to
12 mg/ml and centrifuged to equilibrium at 12,000, 15,000, and
21,000 rpm, respectively, at 20C, and imaged by using interference
optics. The sample distributions measured at equilibrium were fitted
with the program ULTRASPIN (Altamirano et al., 2001) by using
a single-species equation. Any nonideal behavior, such as self-
association, then manifests itself as increasing apparent whole-
cell molecular-weight-average weights (Mw;app) with increasing
concentration. Sedimentation velocity experiments used the same
sample preparation; data were collected by using interference op-
tics and were analyzed with SEDFIT (Schuck and Rossmanith,
2000) in the c(s) mode for the calculation of sedimentation coeffi-
cient distributions. Single species display a Gaussian distribution
in sedimentation coefficient due to the effects of diffusion, about
a central point that is the sedimentation coefficient of the species.
The Gaussian distributions were fitted with the program PROFIT,
and the areas under individual peaks within the distribution were
calculated with the equation
A= sa
ﬃﬃﬃﬃﬃﬃ
2p
p
;
where A is the area, s the half width, and a the height of each peak.
Bead models were calculated for monomeric, dimeric, and tetra-
meric structures of the CRKL domain by using AtoB (Byron, 1997),
with sedimentation coefficients being calculated for those bead
models with SOLPRO (Garcia de la Torre et al., 1999). The theoretical
sedimentation coefficients were used to calculate a range of likely
values for those models in solution, allowing for hydration between
0.1 and 0.5 g H2O/g protein with the equation (Sutton et al., 2004)
sd = s0

1 +

d
vr
1=3
;
where sd is the sedimentation coefficient allowing for hydration of d g
H2O/ g protein, s0 is the sedimentation coefficient calculated by
SOLPRO, v is the partial specific volume of the protein, and r is
the density of the buffer. The range between a hydration of 0.1 g/g
and one of 0.5 g/g was then quoted as a likely range for the sedimen-
tation coefficient of the modeled species.
Isothermal Titration Calorimetry
Experiments were performed essentially as described previously
(Harkiolaki et al., 2003; Lewitzky et al., 2004). The C-terminally
amidated CD34 juxtamembrane domain peptides analyzed(RRSWSPTGER and NRRSWSPTGERLGEDPYYT) were synthesized
and purified by HPLC in the Cancer Research UK Protein and Pep-
tide Chemistry Group by Nicola O’Reilly and coworkers.
Extraction of Cytosolic HeLa Proteins
HeLa cells were grown as adherent culture in excess DMEM supple-
mented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin in a humidified atmosphere at 37C with 10% CO2. Before har-
vesting, cells were washed twice with chilled PBS, twice with chilled
hypotonic lysis buffer (HLB; 10 mM Tris HCl [pH 7.5], 10 mM KCl,
1 mM EDTA, 1 mM EGTA, 2 mM MgCl2), and once with HLB contain-
ing 13 protease inhibitor cocktail (169748, Roche), 0.7 mg/ml pep-
statin A, 13 phosphatase inhibitor cocktails 1 and 2 (P2850 and
P5726, SigmaAldrich), and 1 mM DTT. Cells were left sitting on ice
to swell for 10 min and then scraped and dounce homogenized
(20 strokes with a small clearance pestle). The homogenate was clar-
ified by a 30 min spin with 100,000 3 g at 2C. The supernatant was
collected, leaving the lipid layer on top behind, snap frozen in liquid
nitrogen and stored at 280C until further use. The protein concen-
tration of the S100 fraction was determined by Bradford assay.
Molecular Size-Exclusion Chromatography by FPLC
Purified recombinant full-length CRKL was loaded on a pre-
equilibrated HiLoad Superdex 75 16/60 (Amersham Biosciences) in
50 mM HEPES (pH 7.5), 100 mM NaCl and run at a flow rate of
1 ml/min. The CRKL protein elutes at an experimental molecular
weight of 58 kDa as opposed to the theoretical 33.8 kDa of the mono-
mer. In identical fashion, HeLa cell extracts were run on the same
column. The collected 0.5 ml fractions were separated by SDS-
PAGE, and the resolved proteins transferred onto a Hybond-P mem-
brane (Amersham Biosciences) with a semidry transfer cell. The
membrane was thereafter blocked with TBS-T (20 mM Tris HCl [pH
7.5], 100 mM NaCl, 0.1% Tween, 5% nonfat milk) for 1 hr and incu-
bated overnight with a 1:200 diluted rabbit anti-c-Crk II (H53, sc-
9004; Santa Cruz) or rabbit anti-CRKL (sc-319). Membranes were
then washed with TBS-T, incubated with HRP-coupled donkey
anti-rabbit IgG (Jackson ImmunoResearch Laboratories), washed
again, and finally incubated with ECL detection reagent before
autoradiography.
Supplemental Data
Supplemental Data include a graphical representation of the CRKL
SH3C monomer, along with a primary amino acid sequence align-
ment of CRKL SH3C and its homolog c-CrkII SH3C. These are
followed by a section on the possible implications the reported
dimerization in the molecular interactions CRKL partakes in, such
as loss of phosphorylation potential and signal amplification. Addi-
tional experimental data supporting the persistence of a native
dimer of the full-length CRKL in solution are supplied through cross-
linking experiments accompanied by a figure of SDS-PAGE analysis
of the relevant results followed by a full description of the experi-
mental procedure employed. Supplemental Data further include an
extensive section on the prevalence and physiological importance
of SH3 dimers studied to date accompanied by a section on previ-
ously published molecular simulations that aim to clarify the ener-
getics behind the monomer-dimer interconversion the authors sug-
gest in the main manuscript. Finally, the tetramer/dimer, formed via
disulphide bonds through crystal contacts, is discussed in depth.
This was shown to coexist with the reported monomers/dimers in
solution through analytical ultracentrifugation and could be an indi-
cation of cell-signaling regulation induced through oxidative stress.
A graphical representation of the higher-order associations present
in the crystalline arrangements studied is also supplied. The Supple-
mental Data are available at http://www.structure.org/cgi/content/
full/14/12/1741/DC1/.
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